Comparing Kaltenborn and Mulligan techniques for treating wrist pain in rheumatoid arthritis
Effects of Kaltenborn Versus Mulligan Techniques on Pain, Range of Motion and Functional Disability in Patients With Rheumatoid Arthritis Of The Wrist.
This study is testing whether two different hands-on therapy techniques, Kaltenborn and Mulligan, can help people with wrist pain from rheumatoid arthritis feel better and move more easily.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 34 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Lahore, Punjab Province) |
| Trial ID | NCT06459453 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of two manual therapy techniques, Kaltenborn and Mulligan, on pain, range of motion, and functional disability in patients suffering from rheumatoid arthritis affecting the wrist. Participants aged 18 to 65 with chronic rheumatoid arthritis were randomly assigned to receive either Kaltenborn mobilization or Mulligan mobilization alongside conventional physiotherapy. The study utilized assessments such as the Visual Analogue Scale (VAS) and goniometric measurements to evaluate outcomes after treatment. The goal is to determine which technique is more effective in improving patient outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 65 with chronic rheumatoid arthritis and specific limitations in wrist movement.
Not a fit: Patients with mental illnesses, neurological deficits, or serious upper limb pathologies may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide patients with more effective treatment options for managing pain and improving function in rheumatoid arthritis.
How similar studies have performed: While there is existing literature on manual therapy for rheumatoid arthritis, this specific comparison of Kaltenborn and Mulligan techniques is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age group between 18 to 65 years. Patients with less than 15degrees of flexion and 30 degrees of extension. * Male and female both are included. * Patients with chronic RA. * Consider only those patients with Ra factor positive. Patients with less than 10degrees of radial deviation and 15 degrees of ulnar deviation. * Patients willing to participate in the whole treatment session and follow up. Exclusion Criteria: * Patients who had any mental illness (Alzheimer's, Parkinson's disease, Dementia etc) * Patients who had any neurological deficit(paresthesia ,sensory loss, radiculopathy ,myleopathy) * Peripheral vascular diseases. * Any history of surgery related to upper limb. * Patients having metal implants in the upper limbs. Patients with any other serious pathology .
Where this trial is running
Lahore, Punjab Province
- Shaikh zayed hospital — Lahore, Punjab Province, Pakistan (Recruiting)
Study contacts
- Principal investigator: Hajra Anwer — Riphah International University
- Study coordinator: Imran Amjad, PhD
- Email: imran.amjad@riphah.edu.pk
- Phone: 03324390125
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.